These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
921 related articles for article (PubMed ID: 15699390)
1. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis. Lauriola L; Ranelletti F; Maggiano N; Guerriero M; Punzi C; Marsili F; Bartoccioni E; Evoli A Neurology; 2005 Feb; 64(3):536-8. PubMed ID: 15699390 [TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of immunopathological features of AChR/MuSK autoantibody-negative myasthenia gravis. Hayashi A; Shiono H; Ohta M; Ohta K; Okumura M; Sawa Y J Neuroimmunol; 2007 Sep; 189(1-2):163-8. PubMed ID: 17706794 [TBL] [Abstract][Full Text] [Related]
3. Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG. Leite MI; Ströbel P; Jones M; Micklem K; Moritz R; Gold R; Niks EH; Berrih-Aknin S; Scaravilli F; Canelhas A; Marx A; Newsom-Davis J; Willcox N; Vincent A Ann Neurol; 2005 Mar; 57(3):444-8. PubMed ID: 15732104 [TBL] [Abstract][Full Text] [Related]
4. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509 [TBL] [Abstract][Full Text] [Related]
5. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis. Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539 [TBL] [Abstract][Full Text] [Related]
6. Dropped head syndrome as prominent clinical feature in MuSK-positive Myasthenia Gravis with thymus hyperplasia. Spengos K; Vassilopoulou S; Papadimas G; Tsivgoulis G; Karandreas N; Zambelis T; Manta P Neuromuscul Disord; 2008 Feb; 18(2):175-7. PubMed ID: 18053719 [TBL] [Abstract][Full Text] [Related]
7. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis. Shiraishi H; Motomura M; Yoshimura T; Fukudome T; Fukuda T; Nakao Y; Tsujihata M; Vincent A; Eguchi K Ann Neurol; 2005 Feb; 57(2):289-93. PubMed ID: 15668981 [TBL] [Abstract][Full Text] [Related]
8. Thymus histology and concomitant autoimmune diseases in Japanese patients with muscle-specific receptor tyrosine kinase-antibody-positive myasthenia gravis. Nakata R; Motomura M; Masuda T; Shiraishi H; Tokuda M; Fukuda T; Ando T; Yoshimura T; Tsujihata M; Kawakami A Eur J Neurol; 2013 Sep; 20(9):1272-6. PubMed ID: 23679930 [TBL] [Abstract][Full Text] [Related]
9. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis. Farrugia ME; Robson MD; Clover L; Anslow P; Newsom-Davis J; Kennett R; Hilton-Jones D; Matthews PM; Vincent A Brain; 2006 Jun; 129(Pt 6):1481-92. PubMed ID: 16672291 [TBL] [Abstract][Full Text] [Related]
10. Clinical comparison of anti-MuSK- vs anti-AChR-positive and seronegative myasthenia gravis. Deymeer F; Gungor-Tuncer O; Yilmaz V; Parman Y; Serdaroglu P; Ozdemir C; Vincent A; Saruhan-Direskeneli G Neurology; 2007 Feb; 68(8):609-11. PubMed ID: 17310034 [TBL] [Abstract][Full Text] [Related]
11. MuSK antibody-positive, seronegative myasthenia gravis in Korea. Lee JY; Sung JJ; Cho JY; Oh DH; Kim HJ; Park JH; Lee KW; Choi YC; Vincent A J Clin Neurosci; 2006 Apr; 13(3):353-5. PubMed ID: 16546389 [TBL] [Abstract][Full Text] [Related]